Citigroup’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-42,300
Closed -$261K 7764
2018
Q3
$261K Buy
42,300
+13,300
+46% +$60.1K ﹤0.01% 4964
2018
Q2
$185K Buy
29,000
+19,800
+215% +$141K ﹤0.01% 5150
2018
Q1
$64K Sell
9,200
-7,000
-43% -$81.5K ﹤0.01% 5980
2017
Q4
$204K Sell
16,200
-6,300
-28% -$76.8K ﹤0.01% 5021
2017
Q3
$267K Buy
22,500
+6,400
+40% +$94.9K ﹤0.01% 4734
2017
Q2
$241K Buy
+16,100
New +$215K ﹤0.01% 4638

Other funds holding MDXG

Citigroup's MDXG Position: Q1 2026 in Review

Citigroup increased its MiMedx Group (MDXG) stake by 110% in Q1 2026, buying an estimated $72.6K and bringing the position to 27,545 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #4247.

Citigroup first reported a position in MDXG in Q3 2013 and has held it in 43 quarters since. The position peaked at $7.36M in Q2 2015. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

  • Citigroup held 27,545 shares of MiMedx Group worth $109K as of Q1 2026.
  • Citigroup bought 14,407 MiMedx Group shares in Q1 2026, an estimated $72.6K.
  • MiMedx Group made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4247 holding.
  • Citigroup first reported a position in MiMedx Group in Q3 2013 and has held it in 43 quarters since.
  • Citigroup's MiMedx Group position peaked at $7.36M in Q2 2015.
  • 237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.